skip to primary navigationskip to content

GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

last modified Sep 29, 2016 10:46 AM
The largest genetics laboratory in the NHS brings to the platform their solid tumour sequencing, enabling clinicians to give an individual approach to their patients, tailored to their tumour’s genetic makeup.
GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

 GeneAdvisor's CEO Jelena Aleksic (left) and CTO Robert Stojnic (right)

GeneAdviser is bringing the expertise of Birmingham Women’s Hospital to their ordering platform, where healthcare professionals can now order tests for genetic sequencing of tumour samples, screening for those changes in the tumour that may require clinical action.

Each tumour has a different genetic makeup, which makes it react to therapies very differently. By analysing and monitoring the presence of genetic sequences in a tumour, patients can be prescribed more targeted treatment and screening.

Dr Jelena Aleksic, GeneAdviser’s CEO, commented: “Birmingham Women’s Hospital combines outstanding and comprehensive genetics research and clinical expertise, making it an internationally renowned clinical laboratory. We are delighted to make their excellent genetic testing more accessible to doctors worldwide, helping them provide better care for their patients.”

Professor Michael Griffiths, the Birmingham Women’s Hospital Genetics Laboratory Director, added: "We are excited to join forces with GeneAdviser to facilitate worldwide access to our genetic test portfolio.  As the largest NHS genetics laboratory we already work closely with clinicians across the UK and internationally, and GeneAdviser will allow them to easily order the genetic  tests they need for their patients, whilst streamlining administrative processes for our staff."

Their partnership also expands beyond solid tumour sequencing, bringing forward a selection of high quality genetic tests in oncology and other medical specialties. Other tests from Birmingham Women’s Hospital include their Lucina NIPT (non invasive prenatal testing), a highly accurate genetic prenatal testing that screens for trisomies such as Down syndrome using a single maternal blood sample.

RSS Feed Latest news

Elpis Biomed, GeoSpock and Owlstone Win Cambridge Independent Science and Technology Awards

Nov 04, 2018

Elpis Biomed, based at IdeaSpace South, has scooped 'Start-Up of the Year' award at the Cambridge Independent Science and Technology Awards 2018. ideaSpace alumni Owlstone Medical also took home 'Medtech Company of the Year' and GeoSpock won the 'Technology Company of the Year' award. Congratulations to all!

LESSONS FROM A FOUNDER: Tips for Successful Product Design

Oct 26, 2018

Coming up with an idea for a product is the easy bit - it's the designing of it that can be a complicated and costly process. At a recent ideaSpace event we heard from four founders who offered their insights on how you can build a successful product that your customers are going to love. Read on for tips from our experts.

Camallergy Appoints Baxter Phillips III as CEO

Oct 25, 2018

Camallergy, based at ideaSpace South, a biopharmaceutical company dedicated to providing patient-centric treatments for life-threatening food allergies, has announced the appointment of Baxter Phillips III as Chief Executive Officer. Camallergy co-founder Sherden Timmins continues his executive appointment in the newly created role of Chief Operating Officer.

Mixcloud Strike a Multi-Year Agreement With Universal Music Group 

Oct 19, 2018

ideaSpace West member Mixcloud has signed a deal with the world's largest record label.

Riverlane and dividiti Ring the Bell to Celebrate Hackathon

Oct 18, 2018

ideaSpace West members Riverlane and dividiti celebrate after a successful quantum computing hackathon.

View all news